https://www.pacificbridgemedical.com/news-brief/japans-mhlw-updates-pediatric-drug-development-guidance/ 2026-03-31T20:36:06+00:00 https://www.pacificbridgemedical.com/news-brief/korea-introduces-regulatory-reforms-for-medical-device-change-management/ 2026-03-31T20:36:01+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-april-2026/ 2026-03-31T20:35:58+00:00 https://www.pacificbridgemedical.com/news-brief/china-introduces-market-and-data-exclusivity-in-major-drug-regulatory-reform/ 2026-03-31T20:35:43+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-initiates-early-regulatory-review-for-innovative-medical-devices/ 2026-03-31T20:35:39+00:00 https://www.pacificbridgemedical.com/news-brief/korea-fast-tracks-reimbursement-for-rare-disease-therapies-to-boost-patient-access/ 2026-03-31T20:35:12+00:00 https://www.pacificbridgemedical.com/news-brief/china-expands-udi-requirements-for-class-ii-medical-devices-in-2027/ 2026-03-31T20:34:57+00:00 https://www.pacificbridgemedical.com/news-brief/korea-advances-ai-driven-drug-review-while-attracting-global-biopharma-investment/ 2026-03-31T20:34:46+00:00 https://www.pacificbridgemedical.com/news-brief/japan-moves-to-boost-drug-development-and-address-shortages/ 2026-03-31T20:34:44+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-strengthens-guidelines-for-drug-product-defects-and-recalls/ 2026-03-31T20:34:22+00:00 https://www.pacificbridgemedical.com/news-brief/quick-china-regulatory-updates-march-2026/ 2026-03-03T14:07:03+00:00 https://www.pacificbridgemedical.com/news-brief/japan-moves-to-address-drug-gaps-and-support-overseas-biopharma-trials/ 2026-03-02T20:55:37+00:00 https://www.pacificbridgemedical.com/news-brief/china-tightens-contract-drug-manufacturing-rules/ 2026-03-02T20:53:13+00:00 https://www.pacificbridgemedical.com/news-brief/japan-clarifies-procedures-for-medical-device-raw-material-changes/ 2026-03-02T20:52:52+00:00 https://www.pacificbridgemedical.com/news-brief/cdsco-streamlines-medical-device-reviews-through-stricter-response-timelines-and-pre-filing-guidance/ 2026-03-02T20:52:34+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-march-2026/ 2026-03-02T20:51:25+00:00 https://www.pacificbridgemedical.com/news-brief/thailand-issues-medical-device-labeling-regulation/ 2026-03-02T20:50:37+00:00 https://www.pacificbridgemedical.com/news-brief/korea-expands-expedited-review-for-orphan-drugs/ 2026-03-02T20:50:19+00:00 https://www.pacificbridgemedical.com/news-brief/hsa-confirms-framework-for-ai-samd-regulatory-sandbox-in-singapore/ 2026-03-02T20:49:49+00:00 https://www.pacificbridgemedical.com/news-brief/india-eyes-regulatory-sandbox-model-to-speed-pharma-approvals/ 2026-03-02T20:49:30+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-medical-device-regulatory-updates-february-2026/ 2026-02-02T21:31:13+00:00 https://www.pacificbridgemedical.com/news-brief/china-to-lower-import-tariffs-on-select-medical-products-in-2026/ 2026-02-02T21:14:09+00:00 https://www.pacificbridgemedical.com/news-brief/japan-issues-new-pricing-rules-for-conditionally-approved-regenerative-medicines/ 2026-02-02T21:13:53+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-february-2026/ 2026-02-02T21:13:22+00:00 https://www.pacificbridgemedical.com/news-brief/china-finalizes-2025-national-reimbursement-drug-list-and-launches-first-commercial-insurance-drug-list/ 2026-02-02T21:12:26+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-published-draft-change-management-guidance-for-medical-devices/ 2026-02-02T21:10:42+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-hsa-updates-therapeutic-product-registration-rules/ 2026-02-02T21:09:58+00:00 https://www.pacificbridgemedical.com/news-brief/indias-health-ministry-halves-clinical-trial-approval-timeline-for-drugs-to-45-days/ 2026-02-02T21:09:43+00:00 https://www.pacificbridgemedical.com/news-brief/clinical-trials-in-asia-gain-momentum/ 2026-02-02T21:09:19+00:00 https://www.pacificbridgemedical.com/news-brief/china-revises-pharmaceutical-implementing-regulations-to-boost-innovation-and-market-access/ 2026-02-02T21:08:22+00:00 https://www.pacificbridgemedical.com/news-brief/is-china-still-a-big-opportunity-for-western-healthcare-companies/ 2026-01-07T19:50:10+00:00 https://www.pacificbridgemedical.com/news-brief/china-nmpa-issues-medical-device-sampling-plan/ 2026-01-07T19:47:33+00:00 https://www.pacificbridgemedical.com/news-brief/china-medical-device-update/ 2026-01-07T19:38:25+00:00 https://www.pacificbridgemedical.com/news-brief/china-allows-overseas-labs-for-self-testing-for-medical-device-approval/ 2026-01-07T19:36:17+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-and-china-launch-medical-device-regulatory-reliance-program/ 2026-01-07T19:23:09+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-new-strategic-policy-boosts-medtech-innovation/ 2026-01-07T19:00:44+00:00 https://www.pacificbridgemedical.com/news-brief/china-implements-regulations-on-medical-device-self-testing/ 2026-01-07T18:59:47+00:00 https://www.pacificbridgemedical.com/news-brief/china-amends-good-manufacturing-practice-for-medical-devices/ 2026-01-07T18:56:58+00:00 https://www.pacificbridgemedical.com/news-brief/korea-and-china-accelerate-support-for-medical-device-innovation/ 2026-01-07T18:51:47+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-and-thailand-launch-medical-device-regulatory-reliance-pilot/ 2025-12-23T17:05:37+00:00 https://www.pacificbridgemedical.com/news-brief/japan-to-introduce-pathway-for-specific-use-drug-designations/ 2025-12-23T17:05:19+00:00 https://www.pacificbridgemedical.com/news-brief/china-adds-55-drugs-to-the-new-11th-vbp-round-tightens-rules-on-quality-and-supply-stability/ 2025-12-23T17:03:14+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-and-the-uk-initiate-fast-track-regulatory-pathway-for-breakthrough-health-technologies/ 2025-12-23T17:01:04+00:00 https://www.pacificbridgemedical.com/news-brief/korea-eases-path-to-breakthrough-drugs-with-flexible-incremental-cost-effectiveness-ratio/ 2025-12-23T17:00:54+00:00 https://www.pacificbridgemedical.com/news-brief/china-tightens-oversight-of-excessive-prescribing-raising-risks-for-multinational-drug-companies/ 2025-12-23T17:00:54+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-initiates-health-information-bill/ 2025-12-23T17:00:51+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-regulatory-updates-january-2026/ 2025-12-23T17:00:48+00:00 https://www.pacificbridgemedical.com/news-brief/korea-starts-reforms-to-fast-track-healthcare-approvals-and-improve-rare-disease-access/ 2025-12-23T17:00:43+00:00 https://www.pacificbridgemedical.com/news-brief/japan-medical-device-reimbursement-getting-tougher/ 2025-12-18T16:41:42+00:00 https://www.pacificbridgemedical.com/news-brief/india-releases-draft-guidance-on-medical-device-software/ 2025-12-02T14:14:31+00:00 https://www.pacificbridgemedical.com/news-brief/japans-samd-market-poised-for-rapid-expansion/ 2025-11-30T21:47:10+00:00 https://www.pacificbridgemedical.com/news-brief/china-issues-new-draft-revision-good-clinical-practice-for-drugs/ 2025-11-30T21:44:39+00:00 https://www.pacificbridgemedical.com/news-brief/japan-drug-price-negotiations-continue-for-fy2026/ 2025-11-30T21:42:28+00:00 https://www.pacificbridgemedical.com/news-brief/china-introduces-new-rules-to-regulate-cutting-edge-biomedical-technologies/ 2025-11-30T21:35:28+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-december-2025/ 2025-11-30T21:33:34+00:00 https://www.pacificbridgemedical.com/news-brief/some-innovative-western-devices-pause-before-japan-entry/ 2025-11-30T21:31:55+00:00 https://www.pacificbridgemedical.com/news-brief/korea-expands-access-to-cancer-clinical-trials-for-early-stage-patients/ 2025-11-30T21:29:10+00:00 https://www.pacificbridgemedical.com/news-brief/india-clarifies-packaging-rules-for-medical-devices/ 2025-11-30T21:26:48+00:00 https://www.pacificbridgemedical.com/news-brief/korea-to-now-unveil-full-drug-gmp-inspection-results/ 2025-11-04T16:45:48+00:00 https://www.pacificbridgemedical.com/news-brief/thailand-updates-on-telemedicine-and-advertising/ 2025-11-04T00:29:41+00:00 https://www.pacificbridgemedical.com/news-brief/indonesias-halal-certification-deadlines/ 2025-11-04T00:28:44+00:00 https://www.pacificbridgemedical.com/news-brief/the-malaysia-medical-device-authority-mda-issues-new-regulation-to-expedite-product-registration/ 2025-11-04T00:28:08+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-november-2025/ 2025-11-04T00:27:10+00:00 https://www.pacificbridgemedical.com/news-brief/india-to-extensively-revise-drug-quality-standards/ 2025-11-04T00:26:40+00:00 https://www.pacificbridgemedical.com/news-brief/japan-debating-many-drug-reimbursement-issues-now-for-fy-2026/ 2025-11-04T00:25:21+00:00 https://www.pacificbridgemedical.com/news-brief/china-promulgates-30-day-ind-pathway-for-innovative-drugs/ 2025-11-04T00:23:30+00:00 https://www.pacificbridgemedical.com/news-brief/japan-dramatically-increasing-its-drug-gmp-inspections/ 2025-09-24T18:06:14+00:00 https://www.pacificbridgemedical.com/news-brief/taiwans-fda-releases-updated-guidelines-for-ai-medical-devices/ 2025-09-24T17:38:45+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-2025-drug-reimbursement-update-innovation-and-competition/ 2025-09-24T17:38:36+00:00 https://www.pacificbridgemedical.com/news-brief/thailand-fda-streamlines-renewal-process-for-class-2-3-and-4-medical-devices/ 2025-09-24T17:38:27+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-october-2025/ 2025-09-24T17:38:16+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-implements-revisions-to-clinical-trial-policies-to-streamline-development/ 2025-09-24T17:38:05+00:00 https://www.pacificbridgemedical.com/news-brief/india-seeks-to-relax-clinical-trial-guidelines/ 2025-09-24T17:37:53+00:00 https://www.pacificbridgemedical.com/news-brief/korea-regulatory-updates-october-2025/ 2025-09-24T17:37:44+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-to-use-real-world-evidence-in-drug-listing-decisions/ 2025-09-24T17:37:33+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-regulatory-updates-october-2025/ 2025-09-24T17:37:23+00:00 https://www.pacificbridgemedical.com/news-brief/japan-singapore-singapore-malaysia-advance-cross-border-regulatory-cooperation-on-medical-products/ 2025-09-02T18:25:48+00:00 https://www.pacificbridgemedical.com/news-brief/india-announces-first-formal-guidelines-to-simplify-drug-and-device-approvals/ 2025-09-02T18:24:24+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-updates-guidance-regarding-software-as-a-medical-device-and-clinical-decision-support-software/ 2025-09-02T17:47:33+00:00 https://www.pacificbridgemedical.com/news-brief/japans-mhlw-announces-increased-fy2026-budget/ 2025-09-02T17:45:43+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-hsa-updates-regulatory-guidance-for-therapeutic-drug-registration/ 2025-09-02T00:05:02+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-and-device-regulatory-updates-september-2025/ 2025-09-02T00:00:19+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-ai-drug-companies-secure-multibillion-dollar-big-pharma-partnerships/ 2025-09-01T23:58:08+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-regulatory-updates-september-2025/ 2025-09-01T23:55:43+00:00 https://www.pacificbridgemedical.com/news-brief/japan-plans-to-moderate-its-recruiting-regulations-for-clinical-trials/ 2025-07-31T13:26:10+00:00 https://www.pacificbridgemedical.com/news-brief/japan-now-looking-to-promote-a-single-irb-for-multi-center-studies/ 2025-07-31T13:15:06+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-august-2025/ 2025-07-30T20:52:33+00:00 https://www.pacificbridgemedical.com/news-brief/korea-adopts-ai-use-in-drug-review-and-safety-monitoring/ 2025-07-30T20:51:19+00:00 https://www.pacificbridgemedical.com/news-brief/china-drug-market-access-update-august-2025/ 2025-07-30T20:49:55+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-updates-august-2025/ 2025-07-30T20:46:56+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-promulgates-new-decree-as-part-of-amended-law-on-pharmacy/ 2025-07-30T20:45:21+00:00 https://www.pacificbridgemedical.com/news-brief/india-medical-device-update-august-2025/ 2025-07-30T20:38:35+00:00 https://www.pacificbridgemedical.com/news-brief/china-announces-new-policy-to-support-innovative-drug-development/ 2025-07-30T20:35:34+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-hsa-seeks-feedback-on-ai-samd-regulatory-exemption-for-public-healthcare-use/ 2025-07-07T19:27:19+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-hsa-launches-new-platform-for-medical-device-submissions/ 2025-07-07T19:27:03+00:00 https://www.pacificbridgemedical.com/news-brief/quick-japan-regulatory-updates/ 2025-07-07T18:40:52+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-issues-new-guideline-on-ngs-based-ivd-reagent-classification/ 2025-07-07T18:23:54+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-will-soon-launch-independent-drug-review-system/ 2025-07-07T18:23:38+00:00 https://www.pacificbridgemedical.com/news-brief/japan-starts-to-utilize-ai-to-boost-pharma/ 2025-07-07T18:23:30+00:00 https://www.pacificbridgemedical.com/news-brief/china-moves-to-expedite-clinical-trials-with-30-day-review-proposal/ 2025-07-07T18:23:17+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates/ 2025-07-07T18:23:04+00:00 https://www.pacificbridgemedical.com/news-brief/taiwan-updates-nhi-drug-reimbursement-policies-to-reinforce-drug-supply/ 2025-07-07T18:22:51+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-promulgates-new-regulations-to-streamline-drug-approval/ 2025-07-07T18:22:34+00:00 https://www.pacificbridgemedical.com/news-brief/japan-updates-pharmaceutical-and-medical-device-act-2025/ 2025-06-02T16:00:33+00:00 https://www.pacificbridgemedical.com/news-brief/more-unannounced-fda-inspections-in-china-and-india/ 2025-06-02T16:00:10+00:00 https://www.pacificbridgemedical.com/news-brief/japan-requires-excellent-clinical-data-for-higher-device-reimbursement/ 2025-06-02T15:59:55+00:00 https://www.pacificbridgemedical.com/news-brief/japan-solicits-more-western-drug-companies-to-alleviate-drug-lag/ 2025-06-02T15:58:56+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-regulatory-updates/ 2025-06-02T15:58:40+00:00 https://www.pacificbridgemedical.com/news-brief/mhlw-official-explains-scope-of-expanded-conditional-approval-system/ 2025-06-02T15:58:26+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-7/ 2025-06-02T15:58:13+00:00 https://www.pacificbridgemedical.com/news-brief/trade-frictions-with-china-open-the-door-wider-for-the-indian-medical-device-market/ 2025-06-02T15:58:02+00:00 https://www.pacificbridgemedical.com/news-brief/taiwan-government-to-provide-temporary-funding-for-new-cancer-drugs/ 2025-06-02T15:57:49+00:00 https://www.pacificbridgemedical.com/news-brief/japan-continues-to-update-its-drug-loss-problem/ 2025-05-05T14:28:24+00:00 https://www.pacificbridgemedical.com/news-brief/india-medical-device-regulatory-updates-2/ 2025-05-02T21:00:14+00:00 https://www.pacificbridgemedical.com/news-brief/korea-begins-implementing-immediate-market-entry-medical-technology-initiative/ 2025-05-02T21:00:10+00:00 https://www.pacificbridgemedical.com/news-brief/new-version-of-chinese-pharmacopoeia-published/ 2025-05-02T21:00:05+00:00 https://www.pacificbridgemedical.com/news-brief/japans-pmda-issues-guidance-on-determining-competing-products-in-drug-applications/ 2025-05-02T20:59:59+00:00 https://www.pacificbridgemedical.com/news-brief/asia-pacific-developing-frameworks-for-ai-enabled-medical-technologies/ 2025-05-02T20:59:49+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-national-health-commission-releases-new-guideline-on-human-genetic-resources-management/ 2025-05-02T20:59:39+00:00 https://www.pacificbridgemedical.com/news-brief/china-outlines-pharmaceutical-draft-data-exclusivity-program/ 2025-05-02T20:59:33+00:00 https://www.pacificbridgemedical.com/news-brief/india-to-overhaul-cell-and-gene-therapy-regulatory-approach/ 2025-05-02T20:59:27+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-fda-issues-draft-circular-to-improve-the-recall-system-for-health-products/ 2025-05-02T20:59:20+00:00 https://www.pacificbridgemedical.com/news-brief/urgently-needed-life-saving-therapies-for-singapore/ 2025-04-23T18:23:22+00:00 https://www.pacificbridgemedical.com/news-brief/growing-india-pharma-sector-seeks-freer-hand-from-government/ 2025-04-23T18:22:04+00:00 https://www.pacificbridgemedical.com/news-brief/148-new-drugs-to-be-eligible-for-insurance-reimbursement-in-china/ 2025-04-23T18:20:38+00:00 https://www.pacificbridgemedical.com/news-brief/south-korea-new-agency-to-support-review-innovative-convergence-products/ 2025-04-23T18:19:12+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-seeks-feedback-on-proposed-new-regulations-on-ngs-ivds/ 2025-04-23T18:16:43+00:00 https://www.pacificbridgemedical.com/news-brief/china-hospital-spending-on-cancer-drugs-grows/ 2025-04-23T18:15:12+00:00 https://www.pacificbridgemedical.com/news-brief/india-drafting-expanded-regulations-to-cover-all-medical-devices-on-market/ 2025-04-23T18:04:20+00:00 https://www.pacificbridgemedical.com/news-brief/drug-sales-to-japan-may-suffer-from-new-rules-pharma-leader-warns/ 2025-04-23T18:03:21+00:00 https://www.pacificbridgemedical.com/news-brief/south-korea-regulations-on-ivd-medical-devices-to-go-into-effect-in-2020/ 2025-04-23T18:01:27+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-fine-tunes-medical-device-labeling-requirements/ 2025-04-23T18:00:42+00:00 https://www.pacificbridgemedical.com/news-brief/china-updates-drug-regulations-seeks-comments-by-november-14/ 2025-04-23T17:59:26+00:00 https://www.pacificbridgemedical.com/news-brief/china-moves-to-better-regulate-clinical-trial-pharmaceutical-risks/ 2025-04-23T17:58:24+00:00 https://www.pacificbridgemedical.com/news-brief/china-takes-on-rare-diseases-prioritizing-research-drug-reimbursement/ 2025-04-23T17:56:59+00:00 https://www.pacificbridgemedical.com/news-brief/drug-firms-propose-alternative-to-draft-price-controls-in-the-philippines/ 2025-04-23T17:34:49+00:00 https://www.pacificbridgemedical.com/news-brief/china-approves-clinical-trials-at-more-than-150-new-hospitals-clinics/ 2025-04-23T17:31:19+00:00 https://www.pacificbridgemedical.com/news-brief/korea-eases-approval-licensing-review-of-ai-based-medical-devices/ 2025-04-23T17:30:33+00:00 https://www.pacificbridgemedical.com/news-brief/new-medical-device-requirements-under-consideration-in-malaysia/ 2025-04-23T17:28:32+00:00 https://www.pacificbridgemedical.com/news-brief/china-moves-to-implement-speedier-approvals-of-urgently-needed-drugs/ 2025-04-23T17:28:07+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-releases-draft-of-proposed-regulatory-guidelines-on-software-based-medical-devices/ 2025-04-23T16:15:38+00:00 https://www.pacificbridgemedical.com/news-brief/china-to-institute-national-online-vaccine-tracking-system/ 2025-04-23T16:14:54+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-drafts-new-regulations-on-orphaned-medical-devices/ 2025-04-23T16:14:05+00:00 https://www.pacificbridgemedical.com/news-brief/india-govt-seeks-to-improve-medical-device-regulations-divided-over-how/ 2025-04-23T16:13:26+00:00 https://www.pacificbridgemedical.com/news-brief/two-chinese-provinces-ramp-up-acquisition-of-medical-devices/ 2025-04-23T16:12:52+00:00 https://www.pacificbridgemedical.com/news-brief/more-dmfs-being-filed-in-china/ 2025-04-23T16:10:59+00:00 https://www.pacificbridgemedical.com/news-brief/new-taiwan-medical-device-regulations-still-stalled/ 2025-04-23T16:09:55+00:00 https://www.pacificbridgemedical.com/news-brief/japan-to-begin-implementation-of-new-pharma-medical-device-regulations/ 2025-04-23T16:06:19+00:00 https://www.pacificbridgemedical.com/news-brief/indias-regulatory-agency-clarifies-definition-of-implantable-medical-device/ 2025-04-23T16:02:22+00:00 https://www.pacificbridgemedical.com/news-brief/taiwans-legislature-passes-legislation-separating-regulation-of-medical-devices-from-pharmaceuticals/ 2025-04-23T15:59:25+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-health-authority-to-require-approval-of-medical-device-advertisements-impose-fees/ 2025-04-23T15:58:51+00:00 https://www.pacificbridgemedical.com/news-brief/more-protection-in-chinas-medical-device-market/ 2025-04-23T15:58:00+00:00 https://www.pacificbridgemedical.com/news-brief/korea-institutes-new-drug-regulations-to-boost-safety-speed-approval-of-much-needed-rare-disease-treatments/ 2025-04-23T15:55:25+00:00 https://www.pacificbridgemedical.com/news-brief/to-comply-with-asean-standards-thailand-to-categorize-medical-devices-based-on-risk/ 2025-04-23T15:43:14+00:00 https://www.pacificbridgemedical.com/news-brief/china-u-s-trade-deal-includes-new-protections-for-branded-drugs-conflict-resolution-system/ 2025-04-23T15:41:58+00:00 https://www.pacificbridgemedical.com/news-brief/pharmaceutical-companies-face-barriers-in-singapore/ 2025-04-23T15:17:25+00:00 https://www.pacificbridgemedical.com/news-brief/china-pilots-insurance-reimbursements-for-online-medical-services-in-shanghai/ 2025-04-23T15:16:46+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-releases-new-draft-ivd-and-medical-device-regulations/ 2025-04-23T15:16:03+00:00 https://www.pacificbridgemedical.com/news-brief/new-taiwan-medical-device-law-includes-strict-new-regulations-on-import-distribution/ 2025-04-23T15:15:29+00:00 https://www.pacificbridgemedical.com/news-brief/drug-firms-target-coronavirus-treatments-sought-by-chinese-western-firms/ 2025-04-23T15:14:46+00:00 https://www.pacificbridgemedical.com/news-brief/indonesia-strengthens-oversight-of-medical-device-industry-testing-to-increase/ 2025-04-23T15:13:21+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-eases-medical-device-approval-law-allowing-longer-transition-period/ 2025-04-23T15:12:36+00:00 https://www.pacificbridgemedical.com/news-brief/china-launches-regulation-of-customized-medical-devices-in-boost-for-safety/ 2025-04-23T15:11:52+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-tightens-safety-regulations-on-medical-devices-already-on-market/ 2025-04-23T15:11:11+00:00 https://www.pacificbridgemedical.com/news-brief/south-korea-imposes-new-packaging-labeling-requirements-on-medical-devices/ 2025-04-23T15:05:41+00:00 https://www.pacificbridgemedical.com/news-brief/japan-turns-to-ai-digital-healthcare-to-meet-the-needs-of-an-aging-population/ 2025-04-23T14:59:01+00:00 https://www.pacificbridgemedical.com/news-brief/artificial-intelligence-boom-in-asia-increasingly-affecting-collection-of-data-disease-research/ 2025-04-23T14:58:33+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-cancer-treatments-making-progress/ 2025-04-23T14:54:09+00:00 https://www.pacificbridgemedical.com/news-brief/india-restricts-exports-of-some-pharmaceutical-ingredients-and-formulations-including-chloroquine-phosphate-an-api-which-trump-says-is-used-for-treatment-of-covid-19/ 2025-04-23T14:53:29+00:00 https://www.pacificbridgemedical.com/news-brief/korea-revises-clarifies-labeling-requirements-on-imports-of-unregistered-medical-devices/ 2025-04-23T14:52:12+00:00 https://www.pacificbridgemedical.com/news-brief/indonesia-expected-to-ramp-up-local-content-requirements-for-pharmaceuticals/ 2025-04-22T20:47:49+00:00 https://www.pacificbridgemedical.com/news-brief/non-covid-19-clinical-trials-on-hold-in-singapore-due-to-viral-pandemic/ 2025-04-22T20:47:02+00:00 https://www.pacificbridgemedical.com/news-brief/new-china-quality-control-standards-affect-scores-of-medical-devices/ 2025-04-22T20:46:29+00:00 https://www.pacificbridgemedical.com/news-brief/to-speed-development-of-covid-19-treatments-japan-may-utilize-compassionate-use-regulatory-exemption/ 2025-04-22T20:46:04+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-institutes-new-registration-requirements-on-next-gen-ivds/ 2025-04-22T20:44:54+00:00 https://www.pacificbridgemedical.com/news-brief/draft-2020-chinese-pharmacopoeia-includes-hundreds-of-new-pharmaceuticals/ 2025-04-22T20:44:19+00:00 https://www.pacificbridgemedical.com/news-brief/korea-regulations-on-ivd-go-into-effect/ 2025-04-22T20:39:54+00:00 https://www.pacificbridgemedical.com/news-brief/amid-covid-19-outbreak-china-encourages-online-diagnoses-telehealth-services/ 2025-04-22T20:38:55+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-launches-new-safety-compliance-reporting-system-for-medical-devices/ 2025-04-22T20:38:11+00:00 https://www.pacificbridgemedical.com/news-brief/china-drafts-revisions-to-its-system-for-classifying-pharmaceuticals/ 2025-04-22T20:36:19+00:00 https://www.pacificbridgemedical.com/news-brief/local-agent-responsibilities-grow-for-medical-devices-in-china/ 2025-04-22T20:35:05+00:00 https://www.pacificbridgemedical.com/news-brief/china-publishes-major-revisions-to-pharmaceutical-registration-requirements/ 2025-04-22T20:33:54+00:00 https://www.pacificbridgemedical.com/news-brief/korea-to-require-renewals-of-medical-device-registration-for-the-first-time/ 2025-04-22T20:32:43+00:00 https://www.pacificbridgemedical.com/news-brief/indonesia-pushing-to-mandate-higher-local-content-in-pharmaceuticals/ 2025-04-22T20:29:14+00:00 https://www.pacificbridgemedical.com/news-brief/taiwan-shelves-plan-to-curb-out-of-pocket-charges-for-medical-devices/ 2025-04-22T20:28:21+00:00 https://www.pacificbridgemedical.com/news-brief/new-online-portal-expected-to-speed-therapeutics-applications-in-singapore/ 2025-04-22T20:27:46+00:00 https://www.pacificbridgemedical.com/news-brief/china-takes-leadership-in-cell-and-gene-therapy-research-commercialization/ 2025-04-22T20:26:55+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-tightens-requirements-for-reporting-medical-device-dangers/ 2025-04-21T18:57:44+00:00 https://www.pacificbridgemedical.com/news-brief/clinical-trial-participation-plunges-worldwide-in-asia-due-to-covid-19-pandemic/ 2025-04-21T18:56:27+00:00 https://www.pacificbridgemedical.com/news-brief/demand-for-in-vitro-diagnostic-testing-growing-rapidly-in-asia-pacific/ 2025-04-21T18:55:49+00:00 https://www.pacificbridgemedical.com/news-brief/japan-pmda-cites-cyber-attacks-as-emerging-threat-to-medical-device-security/ 2025-04-21T18:55:17+00:00 https://www.pacificbridgemedical.com/news-brief/china-drafts-new-penalties-on-counterfeit-drugs-pharma-price-manipulation/ 2025-04-21T18:54:10+00:00 https://www.pacificbridgemedical.com/news-brief/indonesia-to-accept-applications-for-its-popular-online-medical-devices-catalogue/ 2025-04-21T18:52:46+00:00 https://www.pacificbridgemedical.com/news-brief/china-to-implement-more-stringent-requirements-for-medical-device-local-agents/ 2025-04-21T18:51:37+00:00 https://www.pacificbridgemedical.com/news-brief/new-tracking-system-expected-to-boost-safety-management-of-implantable-medical-devices-in-korea/ 2025-04-21T18:49:42+00:00 https://www.pacificbridgemedical.com/news-brief/china-new-registration-standards-on-biologic-chemical-drugs-go-into-effect/ 2025-04-21T18:49:02+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-to-speed-and-ease-approval-of-devices-for-decontaminating-respirators/ 2025-04-21T18:48:01+00:00 https://www.pacificbridgemedical.com/news-brief/china-amends-group-medical-insurance-payment-system-pilot-program/ 2025-04-21T18:45:19+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-plans-suspension-of-foreign-pharmaceutical-inspection-approvals/ 2025-04-21T18:43:32+00:00 https://www.pacificbridgemedical.com/news-brief/china-adopts-international-standards-for-clinical-trial-procedures/ 2025-04-21T18:42:54+00:00